Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Exagamglogene autotemcel (Casgevy) en etrasimod (Velsipity) in de sluis geplaatst
mrt 2024 | Benigne hematologie, IBD